LBRX – lb pharmaceuticals inc (US:NASDAQ)
Stock Stats
News
LB Pharmaceuticals initiates Phase 2 trial of LB-102 [Yahoo! Finance]
LB Pharmaceuticals Initiates Phase 2 ILLUMINATE-1 Trial in Bipolar Depression, Expanding LB-102 Development Program
LB Pharmaceuticals Appoints Minako Pazdera, J.D., Ph.D. as General Counsel
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
LB Pharmaceuticals (NASDAQ:LBRX) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
Form SCHEDULE 13G LB PHARMACEUTICALS INC Filed by: BlackRock, Inc.
Form SCHEDULE 13G/A LB PHARMACEUTICALS INC Filed by: BlackRock Portfolio Management LLC
Form SCHEDULE 13G LB PHARMACEUTICALS INC Filed by: JPMORGAN CHASE & CO
Form SCHEDULE 13G LB PHARMACEUTICALS INC Filed by: Trails Edge Capital Partners, LP
Form 4 LB PHARMACEUTICALS INC For: Dec 10 Filed by: Pai Panandiker Kaya Kamlesh
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.